Portola Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2020 to a ratio of 9.1, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Portola Pharmaceuticals Inc in Mar 31 2020 quarter, has decreased to 40 days, compared to 45 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 114 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1366, from overall ranking in the fourth quarter 2019 at 2762.

What is Receivable Turnover Ratio?
What is Portola Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PTLA Receivables Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Receivable Change	-37.13 %	131.61 %	-	-	-
Y / Y Revenue Change	19.04 %	91.19 %	159.57 %	608.65 %	233.67 %
Receivable Turnover Ratio (TTM)	9.1	8.11	8.24	10.14	12.62
PTLA's Total Ranking	# 1366	# 2762	# 1317	# 1532	# 697
Accounts Receivable average collection period days	40	45	44	36	29
Seq. Receivable Change	-45.3 %	-25.71 %	30.68 %	18.39 %	101.52 %
Seq. Revenue Change	-9.78 %	-20.52 %	29.46 %	28.22 %	44.91 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 59
Healthcare Sector	# 115
Overall Market	# 1366

Receivable Turnover Ratio Statistics
High	Average	Low
583.59	61.45	5.52
(Sep 30 2015)		(Dec 31 2014)

PTLA Company Profile • Back to PTLA Efficiency Comparisons • Compare PTLA Receivables Turnover Ratio to its Competitors

Financial Statements
Portola Pharmaceuticals Inc 's Accounts Receivable	$ 7 Millions	Visit PTLA's Balance sheet
Portola Pharmaceuticals Inc 's Sales TTM	$ 121 Millions	Visit PTLA's Income Statement
Sources of PTLA's Revenues		Visit PTLA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PTLA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PTLA's Growth Rates	PTLA's Roa	PTLA's Inventory Turnover Ratio	PTLA's Dividend Comparisons
PTLA's Profitability Ratios	PTLA's Roi	PTLA's Asset Turnover Ratio	PTLA's Dividend Growth
PTLA's Valuation Ratios	PTLA's Roe	PTLA's Financial Strength Ratios	PTLA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Receivable at quarter ending Mar 31 2020
Scorpius Holdings inc	44.25	$ 3.250 Millions	$ 0.073 Millions
Wearable Health Solutions, Inc.	40.30	$ 0.980 Millions	$ 0.024 Millions
National Vision Holdings Inc	38.47	$ 1,732.820 Millions	$ 45.041 Millions
Editas Medicine Inc	37.60	$ 24.185 Millions	$ 0.643 Millions
Endonovo Therapeutics Inc	29.42	$ 0.335 Millions	$ 0.011 Millions
Brookdale Senior Living Inc	29.09	$ 3,982.621 Millions	$ 136.927 Millions
Decoy Therapeutics Inc	28.93	$ 4.480 Millions	$ 0.155 Millions
Reliv International Inc	26.24	$ 35.848 Millions	$ 1.366 Millions
Bellicum Pharmaceuticals Inc	26.10	$ 7.922 Millions	$ 0.304 Millions
Igc Pharma Inc	25.06	$ 4.072 Millions	$ 0.163 Millions
Cardiff Lexington Corporation	24.98	$ 4.734 Millions	$ 0.190 Millions
Cogent Biosciences Inc	24.22	$ 26.477 Millions	$ 1.093 Millions
Advanced Container Technologies Inc	22.87	$ 2.100 Millions	$ 0.092 Millions
Delcath Systems Inc	22.75	$ 1.604 Millions	$ 0.071 Millions
Ascendis Pharma A	22.63	$ 2.452 Millions	$ 0.108 Millions
Tearlab Corp	22.47	$ 22.216 Millions	$ 0.989 Millions
Ernexa Therapeutics Inc	22.45	$ 17.368 Millions	$ 0.774 Millions
Harrow Inc	22.34	$ 50.692 Millions	$ 2.269 Millions
Invo Fertility Inc	22.25	$ 1.549 Millions	$ 0.070 Millions
Immunogen inc	21.90	$ 86.974 Millions	$ 3.971 Millions
Guardion Health Sciences Inc	21.67	$ 0.906 Millions	$ 0.042 Millions
Seres Therapeutics Inc	19.68	$ 35.373 Millions	$ 1.798 Millions
Emmaus Life Sciences Inc	19.07	$ 29.246 Millions	$ 1.533 Millions
Acadia Healthcare Company Inc	18.66	$ 6,418.866 Millions	$ 343.999 Millions
Aveo Pharmaceuticals Inc	18.31	$ 27.968 Millions	$ 1.528 Millions
Precision Biosciences Inc	17.87	$ 23.774 Millions	$ 1.331 Millions
Prothena Corporation Public Limited Company	17.68	$ 0.769 Millions	$ 0.044 Millions
Neurometrix Inc	17.20	$ 8.322 Millions	$ 0.484 Millions
Iqvia Holdings Inc	16.94	$ 11,158.000 Millions	$ 658.750 Millions
Therapeutic Solutions International Inc	16.89	$ 0.045 Millions	$ 0.003 Millions

Date modified: 2026-08-29T17:19:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.